These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29900007)

  • 1. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines.
    Toro-Salazar OH; Lee JH; Zellars KN; Perreault PE; Mason KC; Wang Z; Hor KN; Gillan E; Zeiss CJ; Gatti DM; Davey BT; Kutty S; Liang BT; Spinale FG
    Cardiooncology; 2018; 4():. PubMed ID: 29900007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
    Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
    BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.
    Muehlberg F; Kornfeld M; Zange L; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
    ESC Heart Fail; 2023 Feb; 10(1):616-627. PubMed ID: 36404640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging.
    Wolf CM; Reiner B; Kühn A; Hager A; Müller J; Meierhofer C; Oberhoffer R; Ewert P; Schmid I; Weil J
    Front Pediatr; 2020; 8():123. PubMed ID: 32296665
    [No Abstract]   [Full Text] [Related]  

  • 5. Echocardiographic Assessment of Cardiac Function in Pediatric Survivors of Anthracycline-Treated Childhood Cancer.
    Slieker MG; Fackoury C; Slorach C; Hui W; Friedberg MK; Fan CS; Manlhiot C; Dillenburg R; Kantor P; Mital S; Liu P; Nathan PC; Mertens L
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e008869. PubMed ID: 31826678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of myocardial dysfunction in cardiac morbidity and all cause mortality in childhood cancer subjects treated with anthracycline therapy.
    Toro-Salazar OH; Gillan E; Ferranti J; Orsey A; Rubin K; Upadhyay S; Mazur W; Hor KN
    Cardiooncology; 2015 Nov; 1(1):1. PubMed ID: 33530141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.
    Ganame J; Claus P; Uyttebroeck A; Renard M; D'hooge J; Bijnens B; Sutherland GR; Eyskens B; Mertens L
    J Am Soc Echocardiogr; 2007 Dec; 20(12):1351-8. PubMed ID: 17604960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.
    Jeyaprakash P; Sangha S; Ellenberger K; Sivapathan S; Pathan F; Negishi K
    J Am Heart Assoc; 2021 Mar; 10(6):e018802. PubMed ID: 33660514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Echocardiographic Techniques to Detect Subclinical Cancer Therapeutics-Related Cardiac Dysfunction among High-Dose Patients When Compared with Cardiac Magnetic Resonance Imaging.
    Toro-Salazar OH; Ferranti J; Lorenzoni R; Walling S; Mazur W; Raman SV; Davey BT; Gillan E; O'Loughlin M; Klas B; Hor KN
    J Am Soc Echocardiogr; 2016 Feb; 29(2):119-31. PubMed ID: 26678319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction.
    Harries I; Berlot B; Ffrench-Constant N; Williams M; Liang K; De Garate E; Baritussio A; Biglino G; Plana JC; Bucciarelli-Ducci C
    Int J Cardiol; 2021 Nov; 343():180-186. PubMed ID: 34454967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognostic value of right ventricular dysfunction on cardiovascular magnetic resonance imaging in anthracycline-treated cancer survivors.
    Chhikara S; Hooks M; Athwal PSS; Hughes A; Ismail MF; Joppa S; Velangi PS; Nijjar PS; Blaes AH; Shenoy C
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1222-1230. PubMed ID: 34297807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel microRNA profile in pediatric patients with cancer treated with anthracycline chemotherapy.
    Oatmen KE; Toro-Salazar OH; Hauser K; Zellars KN; Mason KC; Hor K; Gillan E; Zeiss CJ; Gatti DM; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1443-H1452. PubMed ID: 30141982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis.
    Sandamali JAN; Hewawasam RP; Fernando MACSS; Jayatilaka KAPW; Madurawe RD; Sathananthan PP; Ekanayake U; Horadugoda J
    Biomed Res Int; 2020; 2020():1847159. PubMed ID: 33274195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
    Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Myocardial Strain Indices in Children Receiving Anthracycline Chemotherapy.
    Pignatelli RH; Ghazi P; Reddy SC; Thompson P; Cui Q; Castro J; Okcu MF; Jefferies JL
    Pediatr Cardiol; 2015 Dec; 36(8):1610-6. PubMed ID: 26049414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
    Dodos F; Halbsguth T; Erdmann E; Hoppe UC
    Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.
    Tham EB; Haykowsky MJ; Chow K; Spavor M; Kaneko S; Khoo NS; Pagano JJ; Mackie AS; Thompson RB
    J Cardiovasc Magn Reson; 2013 Jun; 15(1):48. PubMed ID: 23758789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.